Collection of Tissue Samples for Cancer Research

This study is currently recruiting participants.
Verified June 2012 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00900198
First received: May 9, 2009
Last updated: April 6, 2013
Last verified: June 2012
  Purpose

Background:

-Patients who are being evaluated in the Developmental Therapeutics Clinic, (DTC)/MOB/CCR/NCI will be entered onto this screening and tissue procurement protocol for collection of tissue specimens.

Objectives:

-To obtain samples for research purposes from tests performed for clinical indications or research indications on other research protocols.

Eligibility:

-Patients who are being evaluated for and treated on protocols within the DTC/MOB/CCR/NCI.

Design:

  • Specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols that a given patient is enrolled in.
  • These procedures may include, but are not limited to, laboratory tests on blood, CSF, urine or other specimens; pulmonary function tests; subspecialty consultations; molecular diagnostics on tumor tissues; radiographic and nuclear medicine studies, which may require the administration of contrast or a radioisotope tracer; and needle or open biopsies for diagnostic purposes.
  • Procedures will not be performed for the sole purpose of obtaining tissue specimens or biological fluids for research purposes. However, research samples for this protocol will be obtained from tests performed for clinical or research indications on other research protocols.
  • Given the risks associated with any procedure, the procedure will be discussed in detail with the patients, including the side effects, prior to obtaining a separate consent for each procedure.
  • Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), and bone marrow. These specimens will be stored with patient identifiers and used to perform only those research studies that are outlined in this protocol.
  • A patient may remain on this study for a period of 1 month at a time. Once a patient is taken off study, he or she may be re-consented and enrolled at a later time to obtain another research specimen as part of this protocol.

Condition
Tissue Analysis

Study Type: Observational
Official Title: Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI)

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 200
Study Start Date: September 2006
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients who are being evaluated for and treated on protocols within the NIH Clinical Center.

Ability to understand and willingness to sign a written informed consent document indicating their willingness to have their tissue or biologic fluid specimens used for research as outlined in this protocol.

Age greater than 18 years

EXCLUSION CRITERIA:

None

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00900198

Contacts
Contact: Shivaani Kummar, M.D. (301) 435-5402 kummars@mail.nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: Shivaani Kummar, M.D.     301-496-4916     kummars@mail.nih.gov    
Sponsors and Collaborators
Investigators
Principal Investigator: Shivaani Kummar, M.D. National Cancer Institute (NCI)
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00900198     History of Changes
Other Study ID Numbers: 060213, 06-C-0213
Study First Received: May 9, 2009
Last Updated: April 6, 2013
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Tissue Collection
Biospecimen
Assay Development
Tissue Acquisition
Tissue Biopsies

ClinicalTrials.gov processed this record on May 19, 2013